Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2005 Sep 30;6(2):E184-9.
doi: 10.1208/pt060227.

Insulin gel as an alternate to parenteral insulin: formulation, preclinical, and clinical studies

Affiliations
Clinical Trial

Insulin gel as an alternate to parenteral insulin: formulation, preclinical, and clinical studies

Reshma D'Souza et al. AAPS PharmSciTech. .

Abstract

The objective of the present study was to formulate insulin gel for intranasal administration and to evaluate with respect to in vitro release studies and hypoglycemic activity in animal model and healthy human volunteers. The insulin gel was formulated using the combination of carbopol and hydroxypropyl methylcellulose as gelling agent. The in vivo efficacy of insulin gel administered intranasally was assessed by measuring the blood glucose levels and serum insulin levels at specified time intervals in rats and humans. The use of bioadhesive nasal gel containing insulin not only promoted the prolonged contact between the drug and the absorptive sites in the nasal cavity but also facilitated direct absorption of medicament through the nasal mucosa. Absorption of the drug through the nasal mucosa was high in the first 0.5 to 1.5 hours of the study with a sharp decline in blood sugar and rise in insulin values corresponding to that decline in blood sugar. This study further demonstrates that administration of insulin intranasally in gel form is a pleasant and painless alternative to injectable insulin.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Pillai O, Panchagnula R. Insulin therapies—past, present and future. Drug Discov Today. 2001;6:1056–1061. doi: 10.1016/S1359-6446(01)01962-6. - DOI - PubMed
    1. Davis SN, Granner DK. Insulin, oral hypoglycemic agents, and the pharmacotherapy of the endocrine pancreas. In: Hardman JG, Limbird LE, editors. The Pharmacological Basis of Therapeutics. 9th ed. New York, NY: McGraw-Hill; 1996. pp. 1487–1517.
    1. Arunachalam S, Gunasekaran S. Diabetic research in India, and China today: from literature-based mapping to health-care policy. Curr Sci. 2002;9–10:1086–1097.
    1. Ugwoke MI, Verbeke N, Kinget R. The biopharmaceutical aspects of nasal mucoadhesive drug delivery. J Pharm Pharmacol. 2001;53:3–22. doi: 10.1211/0022357011775145. - DOI - PubMed
    1. Jiang G, Qiu W, DeLuca PP. Preparation and in vitro/in vivo evaluation of insulin-loaded poly(acryloyl-hydroxyethyl starch)-PLGA composite microspheres. Pharm Res. 2003;20:452–459. doi: 10.1023/A:1022668507748. - DOI - PubMed

Publication types

LinkOut - more resources